Schedule 13G ownership disclosure

Aurinia Pharmaceuticals Inc

Security class unavailable · CUSIP: 05156V102

Event date: 2015-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
618,519
Percent of class
1.9000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001144204-16-082686
Form type
SC 13G/A
Filer
Aurinia Pharmaceuticals Inc.
CIK
CIK 1600620
Filed
Feb 16, 2016
Reporting period
Dec 31, 2015
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub